Alcaftadine
Back to searchMolecule Structure
Scientific Name
Alcaftadine
Description of the Drug
Alcaftadine is a H1 histamine receptor antagonist for ophthalmic use to prevent itching associated with allergic conjunctivitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06766
http://www.drugbank.ca/drugs/DB06766
Brand Name(s)
Lastacaft
Company Owner(s)
Allergan Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1602418 | |
| PharmGKB | PA165958399 | |
| Human Metabolome Database | HMDB0015670 | |
| DrugBank | DB06766 | |
| PubChem: Thomson Pharma | 56342212 | |
| PubChem | 19371515 | |
| Nikkaji | J2.960.992F | |
| EPA CompTox Dashboard | DTXSID80598455 | |
| DrugCentral | 4165 | |
| ChemicalBook | CB21011726 | |
| Guide to Pharmacology | 7587 | |
| rxnorm | LASTACAFT | ALCAFTADINE |
| PubChem: Drugs of the Future | 136349963 | |
| ChEBI | 71023 | |
| ZINC | ZINC000011726211 |
